Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 9.26
+0.17 (1.82%)
Sep 18, 2026, 4:08 PM HKT
Xuanzhu Biopharmaceutical Revenue
Xuanzhu Biopharmaceutical had revenue of 69.44M CNY in the half year ending June 30, 2026, with 333.19% growth. This brings the company's revenue in the last twelve months to 103.32M, up 223.31% year-over-year. In the year 2025, Xuanzhu Biopharmaceutical had annual revenue of 51.77M with 72.03% growth.
Revenue (ttm)
103.32M CNY
Revenue Growth
+223.31%
P/S Ratio
40.19
Revenue / Employee
302.11K CNY
Employees
342
Market Cap
4.79B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 51.77M | 21.68M | 72.03% |
| Dec 31, 2024 | 30.09M | 30.07M | 103,672.41% |
| Dec 31, 2023 | 29.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.